Market research
CGB.AU Cann Global Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.97
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- AU0000038085
- Market cap
- 5M
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.97
About
About Cann Global Limited
Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand. It also engages in the exploration and development of bauxite. The company was formerly known as Queensland Bauxite Limited. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CGB.AU discussion.
5 years, 5 months ago
Cann Global Limited is currently in a long term downtrend where the price is trading 14.1% below its 200 day moving average.
From a valuation standpoint, the stock is 94.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.9.
Cann Global Limited's total revenue rose by 18.7% to $900K since the same quarter in the previous year.
Its net income has increased by 62.3% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 60.8% to $-713K since the same quarter in the previous year.
Based on the above factors, Cann Global Limited gets an overall score of 4/5.